BioCentury
ARTICLE | Clinical News

ReoPro abciximab: Postmarketing study data

April 2, 2012 7:00 AM UTC

The single-blind, international postmarketing INFUSE-AMI trial in 452 patients with ST-segment-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) showed that a...